DrugPatentWatch Database Preview
Alembic Pharms Ltd Company Profile
What is the competitive landscape for ALEMBIC PHARMS LTD, and what generic and branded alternatives to ALEMBIC PHARMS LTD drugs are available?
ALEMBIC PHARMS LTD has seventy-seven approved drugs.
There are five tentative approvals on ALEMBIC PHARMS LTD drugs.
Summary for Alembic Pharms Ltd
| US Patents: | 0 |
| Tradenames: | 68 |
| Ingredients: | 68 |
| NDAs: | 77 |
Drugs and US Patents for Alembic Pharms Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alembic Pharms Ltd | AMLODIPINE BESYLATE AND VALSARTAN | amlodipine besylate; valsartan | TABLET;ORAL | 202713-001 | Apr 3, 2015 | AB | RX | No | No | See Pricing | See Pricing | ||||
| Alembic Pharms Ltd | PREGABALIN | pregabalin | CAPSULE;ORAL | 203459-003 | Jul 19, 2019 | AB | RX | No | No | See Pricing | See Pricing | ||||
| Alembic Pharms Ltd | TADALAFIL | tadalafil | TABLET;ORAL | 204809-003 | Mar 26, 2019 | AB | RX | No | No | See Pricing | See Pricing | ||||
| Alembic Pharms Ltd | DESVENLAFAXINE SUCCINATE | desvenlafaxine succinate | TABLET, EXTENDED RELEASE;ORAL | 204003-002 | Jun 29, 2015 | AB | RX | No | No | See Pricing | See Pricing | ||||
| Alembic Pharms Ltd | FENOFIBRATE | fenofibrate | TABLET;ORAL | 210476-001 | Aug 9, 2019 | AB | RX | No | No | See Pricing | See Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
